A new species of Actinoplanes, which has been deposited with the designation NRRL 5325 at the Northern Utilization Research and Development Division of the U. S. Department of Agriculture, produces a polyene antifungal complex designated as Sch 16656. The complex, consisting of one major and three minor components, is isolated from the fermentation broth by a solvent extraction procedure and purified by precipitation methods. The major component is a heptaene and is highly active in vitro and in vivo against Candida albicans. It is active also against strains of Torulopsis and is significantly more potent orally than candicidin in mice against Candida infections.
Numerous polyene antifungal compounds have been isolated over the years and essentially all of these, with one or two exceptions, are produced by Streptomyces species. A new polyene antifungal agent has been isolated in our laboratories which is produced by an organism belonging to the genus Actinoplanes and is of interest because of its high degree of activity against clinical isolates of Candida albicans. This report describes the fermentation, isolation, and classification of the antifungal complex and preliminary biological studies.
MATERIALS AND METHODS Organism. The producing culture is a new species of Actinoplanes which has been differentiated from all others in this genus. The organism has been deposited in the culture collection of the Northern Utilization Research and Development Division U.S. Department of Agriculture, where it has been designated as NRRL 5325.
Fermentation conditions. All media to be described were prepared in tap water. The inoculum for this culture was prepared with a medium containing ( All fermentations were carried out at 28 C in duplicate 500-ml Erlenmeyer flasks containing 100 ml of medium by using a rotary shaker with 2-inch stroke at 300 rpm for 3 to 4 days. Fourteen-liter tank fermentations of the new Actinoplanes were carried out with an inoculum prepared in two stages. A 25-ml portion of inoculum as described for flask fermentations was transferred to a 2-liter Erlenmeyer flask containing 500 ml of sterile inoculum medium. This second flask was incubated for 48 h with continued agitation at 280 rpm at 28 C.
A 500-ml portion of the culture was transferred to a 14-liter fermentor containing 10 liters of fermentation medium. Fermentations were carried out from 25 to32 C.
Antifungal assays. The antibiotic activity was determined by a spectrophotometric or microbiological procedure. In the former method, the whole broth was extracted with an equal amount of butanol. The solvent layer was removed, and the amount of antibiotic was then estimated by recording the optical density at 382 nm and by comparing it to a standard curve prepared at 382 nm with purified Sch 16656.
The microbiological assay of Sch 16656 is a cylinder cup assay with Saccharomyces cerevisiae ATCC 9763 as the test organism and is similar to that described for nystatin (1).
The standard antibiotic preparation has a defined potency of 1,000 ag/mg. The activity of Sch 16656 against a number of filamentous fungi was compared with candicidin (Table 3) . It is good as, if not better than, candicidin against these organisms.
In vivo studies. The results of the in vivo tests in mice are presented in Table 4 . The activity of Sch 16656 as compared to that of candicidin depended to a considerable extent on the severity of the challenge used. The percentages of survivors in control groups are also shown in Table 4 . In less severe infections. between 1.5 and 5 mg/kg provided protection against death when administered either subcutaneously or orally. When more severe challenges were used, higher drug levels were required. Sch 16656 appears to be slightly more active than candicidin when given subcutaneously, and is substantially more active than candicidin when given orally. 
